Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy

Part of paid clinical trials in Nashville, Tennessee.

Sponsor
Toyos Clinic
Study ID
NCT07560735
Phase
PHASE4
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Lifitegrast Ophthalmic Solution 5.0% (Xiidra) — DRUG
    30 subjects with DED will receive lifitegrast ophthalmic solution 5.0% (Xiidra)

Study Details

This is a single center, open label trial to evaluate Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease using In Vivo Confocal Microscopy (IVCM

Key Dates

Start date
Apr 30, 2026
Status verified
Apr 2026
Primary completion
Sep 30, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: DED subjects treated with lifitegrast ophthalmic solution 5.0% (Xiidra)
    30 subjects with DED receiving lifitegrast ophthalmic solution 5.0% (Xiidra)

Primary Outcome Measure

Change in immune cell density in subjects with dry eye disease treated with lifitegrast [ Time Frame: 84 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
West Tennesse Eye Care dba Toyos ClinicNashvilleTennessee37215
Melissa Toyos, MD
[email protected]
615-327-4015
Harley Cheney
[email protected]
615-327-4015

Find similar trials in Nashville, TN

By research site
West Tennesse Eye Care dba Toyos Clinic· Nashville, TN

Related Studies